ESH 4th How to Diagnose and Treat Lymphoma will be held from November 1-3, 2024 at Stockholm, Sweden. ESH (European School of Haematology)'s 'How to Diagnose and Treat' meetings are specialized, disease-specific events designed to
Lung cancer highlights from the ESMO Congress 2024 by SPCC will take place at November 5th, 2024. It is a live webinar by SPCC which will be futuring Aleksandra Filipovic, Alfredo Addeo, Christian Rolfo. The
The 4th APHOG & SIOP Asia Joint Scientific Symposium 2024 will focus on the topic of Retinoblastoma. This event will take place via Zoom on Wednesday, November 6, 2024. The session will be held from
16th European Multidisciplinary Congress on Urological Cancers EMUC 2024 will take place in Lisbon, Portugal, from 7 to 10 November 2024. Top experts in medical oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology gathered
Frontiers in gynaecological oncology will be held at Pristina, Kosovo from November 7-8, 2024. The European School of Oncology offers support to Clinical Institutes through its Visiting Professorship Meeting (VPM) initiative. This program is designed
London Global Cancer Week 2024 will be held from November 11-15, 2024 at London, UK. In 2016, the Royal Society of Medicine Oncology Section initiated annual one-day meetings aimed at improving global cancer outcomes. This
42nd Annual CFS: Innovative Cancer Therapy for Tomorrow will be held from November 13-15, 2024 at New York, USA. Entering its 42nd year, the Chemotherapy Foundation Symposium (CFS) remains a premier event that brings together
The 2024 China Conference on Integrative Oncology will be held from November 14-17, 2024 at Xi'an, China. Organized by the China Anti-Cancer Association, Xijing Hospital of the Air Force Medical University, and others, the conference
The ESH-EBMT-EHA-IPIG 3rd Translational Research Conference on Bone Marrow Failure and Leukaemia Predisposition Syndromes will be held at Paris, France from November 15-17, 2024. It will offer valuable insights for both clinical and non-clinical scientists,
Overview and clarification of the current HR+ HER2- EBC treatment landscape by SPCC will be held at November 27, 2024. It is a live webinar by SPCC and the event will feature presentations on the
